Skip to main content
Premium Trial:

Request an Annual Quote

If They Get a Lot of Attention, Does It Really Matter Whether They're Right?

The Economist has a story following a PLoS Medicine paper from John Ioannidis and colleagues which argues that scientific publishing may be biased toward high-profile papers that may have less accurate findings. "With so many scientific papers chasing so few pages in the most prestigious journals, the winners could be the ones most likely to oversell themselves," the article says. Ultimately, that might "make it more likely that the leading journals will publish dramatic, but what may ultimately turn out to be incorrect, research."

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.